Stephen E. Macadam has seen fluctuating wealth tied to his holdings in BlueLinx. His stock holdings peaked at 600,000 shares of restricted stock when he joined the company in 2014. As of 2018, his vested stock was valued at around...

Stephen E. Macadam has seen fluctuating wealth tied to his holdings in BlueLinx. His stock holdings peaked at 600,000 shares of restricted stock when he joined the company in 2014. As of 2018, his vested stock was valued at around $777,397. The value of his holdings reflects not only his commitment to the company but also the volatility often seen in the market. Each year, his stock options and grants reveal the company’s performance based on set criteria, such as Adjusted EBITDA. Over the years, his stock options have varied due to performance metrics, emphasizing the relationship between the company's success and his financial outcomes. In 2018, his total stock value included both vested and unvested shares, showcasing a strategic plan for wealth acquisition through stock ownership, primarily based on company performance.